Markets
Agetech investment round-up featuring Life Biosciences, Eli Lilly, L-Nutra & LinkGevity The first quarter of 2026 has been a record one in healthy-ageing finance with some US$3.74bn of investment across 49 deals - an increase of 56% in total financing against the same period last year And, the second quarter has gotten off to a [...]
Alzheimer’s drug pioneer Anavex is pressing ahead with plans to secure approval for its ground-breaking treatment despite a recent setback. Earlier this year it lodged an appeal against the European Medicines Agency (EMA) decision to reject its application for drug approval in December 2025. But, Anavex has now withdrawn this appeal as it seeks to [...]
MINNESOTA-based Medtronic has agreed to acquire neurovascular technology company Scientia Vascular for US$550m. Scientia’s neurovascular access devices are used to navigate the brain's complex vasculature, helping prevent cognitive decline by treating conditions such as strokes and aneurysms. The Scientia proposal is Medtronic’s second deal of the year, after the company announced an acquisition of CathWorks [...]
Vision-restoration company Science Corp has closed a US$230m Series C financing round which will allow it to complete the commercialisation of its brain-computer interface, retinal implant, known as PRIMA. The deal, which was oversubscribed, secured participation from pre-existing investors Khosla Ventures, Lightspeed Venture Partners, Y Combinator, IQT, and Quiet Capital amongst others. It raised the [...]
A vision implant firm has raised US$230m as it seeks approval in Europe and the US for a device that restored sight in a small clinical trial. The Alameda, California-based startup said the funding would support commercialisation of its Prima device. It said an upcoming launch is planned in Europe and that it would become [...]
Super-ageing key, Seaweed’s special, hair-raising breakthrough and more The secret of how ‘super-agers’ have the mental agility of people decades younger is centred around brain health, say US researchers. Some elderly people are able to regenerate brain cells twice as quickly as other, healthy adults, of the same age. While it has recently been established [...]
Less than a year after unveiling plans to spin off its diabetes division, Medtronic has confirmed it is seeking to raise US$784 million through an initial public offering of its MiniMed business. The company intends to offer 28 million ordinary shares at an expected price range of US$25 to US$28 per share. Underwriters will be [...]
Global market to hit US$740bn in 2026, longevity needs lifts? ‘little brain’s’ big role, ageing ethics questioned…and more IRISH insight and analysis company Research and Markets estimates the global ageing economy will surpass US$740bn this year. These projections by the company, which is based next to the Guinness Brewery in Dublin, come in its latest [...]
Nyra health has raised €20m to scale its digital neurotherapy platform for neurological rehabilitation, targeting conditions such as stroke and dementia. The Series A funding will be used to expand the company’s technology across the DACH region, accelerate its expansion into the US and support a more data-driven approach to neurorehabilitation. Founded in 2021, Vienna-based [...]
Astellas has agreed a US$1.7bn global prostate cancer deal with Vir Biotechnology to develop a masked T-cell engager designed to harness the immune system against the disease. The collaboration centres on VIR-5500, a PSMAxCD3 bispecific drug known as a T-cell engager, or TCE. TCEs activate immune cells called T cells and direct them to attack [...]
